GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Afrocentric Investment Corp Ltd (JSE:ACT) » Definitions » Cash Ratio

Afrocentric Investment (JSE:ACT) Cash Ratio : 0.19 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Afrocentric Investment Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Afrocentric Investment's Cash Ratio for the quarter that ended in Dec. 2023 was 0.19.

Afrocentric Investment has a Cash Ratio of 0.19. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Afrocentric Investment's Cash Ratio or its related term are showing as below:

JSE:ACT' s Cash Ratio Range Over the Past 10 Years
Min: 0.12   Med: 0.46   Max: 2.61
Current: 0.19

During the past 13 years, Afrocentric Investment's highest Cash Ratio was 2.61. The lowest was 0.12. And the median was 0.46.

JSE:ACT's Cash Ratio is ranked worse than
73.5% of 649 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs JSE:ACT: 0.19

Afrocentric Investment Cash Ratio Historical Data

The historical data trend for Afrocentric Investment's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Afrocentric Investment Cash Ratio Chart

Afrocentric Investment Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.25 0.25 0.14 0.17

Afrocentric Investment Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.14 0.12 0.17 0.19

Competitive Comparison of Afrocentric Investment's Cash Ratio

For the Medical Care Facilities subindustry, Afrocentric Investment's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Afrocentric Investment's Cash Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Afrocentric Investment's Cash Ratio falls into.



Afrocentric Investment Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Afrocentric Investment's Cash Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash Ratio (A: Jun. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=189.763/1114.364
=0.17

Afrocentric Investment's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=189.297/980.604
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Afrocentric Investment  (JSE:ACT) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Afrocentric Investment Cash Ratio Related Terms

Thank you for viewing the detailed overview of Afrocentric Investment's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Afrocentric Investment (JSE:ACT) Business Description

Traded in Other Exchanges
N/A
Address
37 Conrad Road, Florida North, Roodepoort, ZAF, 1709
Afrocentric Investment Corp Ltd is a black-owned investment holding company with an investment portfolio focused on services to the healthcare sector. It seeks to invest in healthcare-related businesses that demonstrate prospects for growth as well as diversify its revenue sources while contributing to the sustainable health and welfare of South African communities. The company provides health administration and health risk management solutions to the healthcare industry. It also provides a range of complementary services to its traditional medical scheme clients and a portfolio of healthcare-related enterprises. These services include information technology solutions, transactional switching, specialized disease management, pharmaceutical wholesaling, amongst others.

Afrocentric Investment (JSE:ACT) Headlines

From GuruFocus

Enact Announces Quarterly Dividend

By PurpleRose PurpleRose 08-11-2022

Enact Announces Neenu Kainth as Chief Customer Experience Officer

By GlobeNewswire GlobeNewswire 08-22-2022

Enact Announces Quarterly Dividend

By Marketwired 08-15-2023

Enact to Host Fourth Quarter 2022 Earnings Call February 7th

By GlobeNewswire GlobeNewswire 01-06-2023

Enact Receives Ratings Upgrade from Fitch Ratings

By sperokesalga sperokesalga 04-25-2023

Enact Receives Ratings Upgrade from Moody's

By sperokesalga sperokesalga 03-01-2023

Enact Reports Second Quarter 2023 Results

By Marketwired 08-01-2023